Pfizer (NYSE:PFE) shares trended higher premarket Wednesday after the company topped expectations with its Q1 2024 financials ...
Pfizer (PFE) beats first-quarter estimates for earnings and sales. It raises 2024 earnings guidance while retaining revenue ...
Benzinga.com on MSN22h
GSK Sees Strong Demand For Vaccines and Asthma Drugs, Raises Annual OutlookGSK expects 2024 adjusted EPS growth of 8% to 10%, up from the 6%-9% growth previously forecast. Shingrix sales reached £945 ...
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on BioNTech SE (BNTX – Research Report), ...
UK pharma major GSK (LSE: GSK) has launched a lawsuit against Pfizer (NYSE: PFE) and BioNTech (Nasdaq: BNTX).
Ratings for BioNTech BNTX were provided by 11 analysts in the past three months, showcasing a mix of bullish and bearish ...
Baillie Gifford's 13F portfolio value increased from ~$126B to ~$129B this quarter. The top three holdings in the portfolio ...
According to France Bleu Mayenne, François-Xavier Fumu Tamuzo will take Pfizer and BioNTech laboratories to court after ...
SHANGHAI/SUZHOU, China (Reuters) - China's vaccine developers stuck with unused mRNA COVID shots and idle manufacturing ...
Seeking Alpha on MSN4d
WHO picks JN.1 variant for next set of COVID vaccinesFollowing a meeting of an advisory panel this week, the World Health Organization (WHO) recommended drugmakers to update ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results